Daniel L. Kisner - May 28, 2021 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
Director
Signature
Daniel L. Kisner, M.D., by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
DVAX
Transactions as of
May 28, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 07:06 PM
Previous filing
May 27, 2021
Next filing
Aug 5, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Option (Right to Buy) Award +25K 25K May 28, 2021 Common Stock 25K $8.20 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests fully on May 28, 2022, on the one year anniversary of the grant date.
F2 Not applicable.